Publications by authors named "Amy H Comander"

Claim this Profile
D
Do cancer curvivors and metavivors have distinct needs for stress management intervention? Retrospective analysis of a mind-body survivorship program.
Lucy Finkelstein-Fox, Cayley C Bliss, Autumn W Rasmussen, Daniel L Hall, Areej El-Jawahri, Amy H Comander

Support Care Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing psychosocial mediators of a mind-body resiliency intervention for cancer survivors.
Lucy Finkelstein-Fox, Autumn W Rasmussen, Daniel L Hall, Giselle K Perez, Amy H Comander

Support Care Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update.
Neelima Denduluri, Mark R Somerfield, Mariana Chavez-MacGregor, Amy H Comander, Zoneddy Dayao

J Clin Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflections on the Boston Marathon from a Breast Cancer Oncologist (or, Why I Just Don't Quit).
Amy H Comander

Oncologist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate.
Amir T Fathi, Hossein Sadrzadeh, Amy H Comander, Michaela J Higgins, Aditya Bardia

Oncologist· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.
Nadine Tung, Yihong Wang, Laura C Collins, Jennifer Kaplan, Hailun Li, Amy H Comander

Breast Cancer Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis